Publications & Reports

Results from the 2023 WA State Syringe Services Program Health Survey.
Kingston S, Newman A, Banta-Green C, Glick S.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2024.

Trends in varenicline use for tobacco cessation, and their implications.
Khan Z, Harris JR, Dearden L, Strait M, Treend K, Glesman H, Carlini BH.
J Amer Pharm Assoc 2024:102102 (in press).

PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high.
Hatch MA, Laschober TC, Paschen-Wolff M, Ertl MM, Nelson CM, Wright L, Lancaster C, Feaster DJ, Forrest D, Hankey C, Monger M, Fegley JP, Irving R, Young C, Rose J, Spector A, Dresser L, Moran L, Jelstrom E, Tross S.
Drug and Alcohol Dependence 2024; 257:111133.

Emergency room utilization and methamphetamine overdose symptoms among syringe services program participants in Washington State.
Frank ND, Banta-Green CJ, Guthrie BL, Kingston S, Tinsley J, Whiteside L, Glick SN.
Substance Use & Misuse 2024 (in press).

Identifying policy options to regulate high potency cannabis: A multiple stakeholder concept mapping study in Washington State, USA.
Carlini BH, Garrett SB, Matos P, Nims LN, Kestens Y.
International Journal of Drug Policy 2024;123:104270.

Community Drug Checking Network: The Use and Impact of Community Drug Checking Services.
Kingston S, Biamont B, Banta-Green C.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2023.

Treatment Medications for Fentanyl Use Disorder: Prescriber Practices and Support Needs in WA State.
Banta-Green C, Duncan M.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2023.

It is time to broaden community dissemination of cognitive-behavioral therapy for substance use disorders: Charting pathways to ascend the remaining mountainside.
Hartzler B.
Clinical Psychology: Science and Practice 2023; 30(2):147-149.

Cannabis Research Report, 2021-2023.
Carlini B, Garrett S, Kellum L, Nims L.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2023.

The Status of Medications for Opioid Use Disorder (MOUD) Provision in Washington State Jails, 2021.
Owens M, Borges A, McGrath J, Stern MF.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2023.

Program director reports of COVID-19 lockdown-driven service changes in community-based STI clinics and syringe services programs in the southeastern U.S.
Hatch MA, Laschober TC, Ertl MM, Paschen-Wolff MM, Norman G, Wright L, Tross S.
AIDS Educ Prev 2024;36(2):129-40.

“I go out of my way to give them an extra smile now”: A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
Irwin AN, Gray M, Ventricelli D, Boggis JS, Bratberg J, Floyd AS, et al.
Research in Social and Administrative Pharmacy 2024 (in press).

Threat, distract, and discredit: cannabis industry rhetoric to defeat regulation of high THC cannabis products in Washington State, USA.
Carlini BH, Kellum LB, Garrett SB, Nims LN.
Journal of Studies on Alcohol and Drugs 2024 (in press).

Food hardship as a strong predictor of tobacco and cannabis use among youth in WA state.
Harwick RM, Carlini BH, Williams JR.
Children and Youth Services Review 2024;157:107427. [free link, expires 3/4/2024]

Unmet Needs, Complex Motivations, and Care for People Using Fentanyl in Washington State: A Qualitative Study.
Winstead T, Newman A, Maroon E, Banta-Green C.
Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2023.

Reducing racial/ethnic disparities with a three-year case management program for mothers with problematic prenatal substance use, Washington State, 2006-2017.
Stoner SA, Graham JC, Grant TM.
BMC Public Health 2023 (in press).

How should policy makers regulate the tetrahydrocannabinol content of cannabis products in a legal market? [opinion]
Hall W, Leung J, Carlini BH.
Addiction 2023;118(6):998-1003.

Perspectives on medication treatment for opioid use disorder in adolescents: Results from a provider learning series.
Peavy KM, Adwell A, Owens MD, Banta-Green CJ.
Substance Use & Misuse 2023;58(1):160-162.

A trauma-informed parenting intervention model for mothers parenting young children during residential treatment for substance use disorder.
Jirkowic T, Graham CJ, Grant T.
Occupational Therapy in Mental Health 2023;39(2):156-183.